Skip to content

NEUROCRINE BIOSCIENCES INC: filings

Every NEUROCRINE BIOSCIENCES INC annual and quarterly report in the SEC record with the published financial measures it tagged, 61 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-07-31fiscal Q2 2026481330000914475-26-000037
10-Q2026-05-05fiscal Q1 202642880000914475-26-000026
10-K2026-02-11fiscal FY 2025481260000914475-26-000007
10-Q2025-10-28fiscal Q3 2025441200000914475-25-000181
10-Q2025-07-30fiscal Q2 2025441200000914475-25-000158
10-Q2025-05-05fiscal Q1 202543900000914475-25-000100
10-K2025-02-10fiscal FY 2024491300000914475-25-000037
10-Q2024-10-30fiscal Q3 2024441200000914475-24-000211
10-Q2024-08-01fiscal Q2 2024441200000914475-24-000181
10-Q2024-05-01fiscal Q1 202444920000914475-24-000117
10-K2024-02-09fiscal FY 2023481280000914475-24-000054
10-Q2023-10-31fiscal Q3 2023451240000914475-23-000073
10-Q2023-08-01fiscal Q2 2023451240000914475-23-000057
10-Q2023-05-03fiscal Q1 202344920000914475-23-000044
10-K2023-02-09fiscal FY 2022491290000914475-23-000011
10-Q2022-11-01fiscal Q3 2022421180000914475-22-000058
10-Q2022-08-04fiscal Q2 2022421180000914475-22-000044
10-Q2022-05-04fiscal Q1 202240840000914475-22-000022
10-K2022-02-11fiscal FY 2021461220000914475-22-000013
10-Q2021-11-01fiscal Q3 2021411140000914475-21-000058
10-Q2021-08-03fiscal Q2 2021411140000914475-21-000047
10-Q2021-05-05fiscal Q1 202141860000914475-21-000036
10-K2021-02-05fiscal FY 2020471780000914475-21-000020
10-Q2020-11-09fiscal Q3 2020421150000914475-20-000036
10-Q2020-08-03fiscal Q2 2020421150000914475-20-000018
10-Q2020-05-06fiscal Q1 202040830001564590-20-021952
10-K2020-02-07fiscal FY 2019441680001564590-20-003773
10-Q2019-11-04fiscal Q3 2019401150001564590-19-039803
10-Q2019-07-29fiscal Q2 2019421170001564590-19-026602
10-Q2019-04-29fiscal Q1 201937750001564590-19-013745
10-K2019-02-08fiscal FY 2018431730001564590-19-002328
10-Q2018-11-05fiscal Q3 201835980001564590-18-026844
10-Q2018-07-31fiscal Q2 201831840001564590-18-018151
10-Q2018-04-30fiscal Q1 201825520001564590-18-009860
10-K2018-02-13fiscal FY 2017371400001193125-18-042794
10-Q2017-11-01fiscal Q3 201727740001193125-17-329460
10-Q2017-08-03fiscal Q2 201727740001193125-17-247437
10-Q2017-05-09fiscal Q1 201724500001193125-17-164338
10-K2017-02-14fiscal FY 2016341160001193125-17-043838
10-Q2016-11-02fiscal Q3 201624670001193125-16-757122
10-Q2016-08-03fiscal Q2 201624670001193125-16-670128
10-Q2016-05-05fiscal Q1 201624510001193125-16-580036
10-K2016-02-11fiscal FY 2015341160001193125-16-459862
10-Q2015-10-29fiscal Q3 201525720001193125-15-358050
10-Q2015-07-29fiscal Q2 201526740001193125-15-268390
10-Q2015-04-30fiscal Q1 201525540001193125-15-161293
10-K2015-02-09fiscal FY 2014351180001193125-15-039176
10-Q2014-11-04fiscal Q3 201426730001193125-14-395717
10-Q2014-08-06fiscal Q2 201426730001193125-14-298386
10-Q2014-05-01fiscal Q1 201426550001193125-14-176441
10-K2014-02-11fiscal FY 2013381580001193125-14-045619
10-Q2013-10-29fiscal Q3 201329790001193125-13-416082
10-Q2013-07-26fiscal Q2 201329790001193125-13-304433
10-Q2013-05-02fiscal Q1 201329610001193125-13-196338
10-K2013-02-08fiscal FY 2012361540001193125-13-045687
10-Q2012-10-31fiscal Q3 201234960001193125-12-443884
10-Q2012-07-31fiscal Q2 201234960001193125-12-325993
10-Q2012-05-02fiscal Q1 201233680001193125-12-204755
10-K2012-02-09fiscal FY 201133890001193125-12-048679
10-Q2011-10-31fiscal Q3 201132890001193125-11-288728
10-Q2011-07-29fiscal Q2 201132900001193125-11-202566

Inspect the source

Entity
NEUROCRINE BIOSCIENCES INC / CIK 0000914475
Captured
2026-09-20T05:07:04.284Z
SEC response SHA-256
7e9732999d54c7ad0c4b2ed55776e124744b1ccfe4813cfa38325dcda176702c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000914475.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))